Since reports showing elevated levels of circulating IL-6 in men with advanced prostate cancer (Twillie et al, 1995; Drachenberg et al, 1999), a number of studies have been performed to clarify how IL-6 signalling is involved in the progression of prostate cancer. This evidence concerns the gene IL6 and prostate carcinoma.